Peritoneal Carcinomatosis A Multidisciplinary Approach /

Recent developments in regional and systemic anticancer therapies have improved the grim outlook of patients with peritoneal carcinomatosis (PC) from ovarian or gastrointestinal origin, leading to a renewed interest in both the underlying mechanisms at the origin of PC and the various therapeutic op...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Ceelen, Wim P. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Boston, MA : Springer US, 2007.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Peritoneal Carcinomatosis: Basic Concepts
  • Structure and Function of Mesothelial Cells
  • Molecular Biology of Peritoneal Carcinomatosis
  • Role of Adhesion Molecules in Locoregional Cancer Spread
  • Surgical Trauma, Minimal Residual Disease and Locoregional Cancer Recurrence
  • Pseudomyxoma Peritonei Syndrome: Classification of Appendiceal Mucinous Tumours
  • The Pathogenesis of Malignant Ascites
  • Natural History of Peritoneal Carcinomatosis from Digestive Origin
  • The Rationale for Intraperitoneal Heat and Drug Therapy
  • Intraperitoneal Drug Therapy: Physical and Biological Principles
  • Current Status of Intraperitoneal Antineoplastic Drug Delivery
  • The Biologic Rationale of Hyperthermia
  • Interactions between Hyperthermia and Cytotoxic Drugs
  • Pharmacodynamic Aspects of Intraperitoneal Cytotoxic Therapy
  • Cytoreductive Surgery for Peritoneal Carcinomatosis: Techniques and Methods
  • Patient Selection for Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion
  • Staging and Scoring of Peritoneal Carcinomatosis
  • Peritonectomy Procedures
  • Continuous Peritoneal Perfusion: Techniques, Methods and Applications
  • Handling of Chemotherapeutic Drugs in the OR: Hazards and Safety Considerations
  • Clinical Results of Surgery with or without Intraperitoneal Heated Drug Therapy
  • Results of Cytoreduction followed by HIPEC in Carcinomatosis of Colorectal Origin
  • HIPEC with Oxaliplatin in the Treatment of Peritoneal Carcinomatosis of Colorectal Origin
  • Clinical Results of Cytoreduction and HIPEC in Pseudomyxoma Peritonei
  • The Impact of Therapy in the Treatment of Pseudomyxoma Peritonei
  • Clinical Results of Cytoreduction and HIPEC for Malignant Peritoneal Mesothelioma
  • Cytoreduction and Intraperitoneal Chemotherapy for Carcinomatosis from Gastric Cancer
  • Cytoreduction and Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Cancer
  • The role of Neoadjuvant Chemotherapy versus Primary Surgery in the Management of Stage III Ovarian Cancer
  • Morbidity and Quality of Life following Cytoreduction and HIPEC
  • Detection and Treatment of Recurrent Disease after Cytoreduction and HIPEC
  • Nonoperative and Multimodal Management of Peritoneal Carcinomatosis
  • Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer
  • Systemic Chemotherapy in patients with Peritoneal Carcinomatosis from Non Colorectal Origin
  • The Role of Radiotherapy in the treatment of Peritoneal Carcinomatosis
  • Medical and Palliative Management of Malignant Ascites
  • Experimental Approaches
  • Targeted Intraabdominal Chemotherapy for Peritoneal Carcinomatosis
  • Immunotherapy of Peritoneal Carcinomatosis
  • Intraperitoneal Photodynamic Therapy
  • Intraperitoneal Gene Therapy.